VIE/VVYN (VIE/VVYN)

Vienna Stock Exchange: VIE/VVYN · EUR

€0.83

+0.01 (+1.0%)· Recorded snapshot

Market cap	24.4M
Net income (ttm)	-6.8M
EPS (ttm)	-€0.24

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -6.8M
EPS (ttm): -€0.24
Market cap: 24.4M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-285.2

P25 n/aP50 n/aP75 n/a

ROIC-173.2

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

S&P 500-0.5%

Nasdaq Composite-4.9%

Dow Jones Industrial Average+2.2%

Russell 2000+1.2%

All VIE/VVYN indicators

Market & fundamental data

Available fields

141

Groups with data

Currency

EUR

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Netherlands
Country code	AT
Earnings date	2026-12-07
Employees	13
Employees change	-1
Employees growth	-6.67%
Enterprise value	EUR 22M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1997
Industry	Biotechnology
Is primary listing	No
ISIN number	NL00150002Q7
Last earnings date	2026-08-06
Last refreshed	2026-10-30
Market cap	EUR 24.4M
Next earnings date	2026-12-07
Price	EUR 0.83
Price currency	EUR
Sector	Healthcare
SIC code	2836
Stock price date	2026-10-29
Symbol	vie/VVYN
Website	https://www.vivoryon.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-28.52%
FCF / EV yield	-32.25%
FCF yield	-29.12%
P/B ratio	15.59x
Price / tangible book value	30.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Profit per employee	EUR -520,615
ROA	-80.06%
ROA (5Y)	-54.8%
ROCE	-194.88%
ROE	-285.21%
ROE (5Y)	-111.63%
ROIC	-173.17%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth quarters	4
EPS growth years	3
Net income growth quarters	4
Net income growth years	2
Revenue growth years	0

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -2,000
Depreciation and amortization	EUR 77,000
EBIT	EUR -6.8M
EBITDA	EUR -6.7M
EPS	EUR -0.24
Financing cash flow	EUR 4.7M
Free cash flow	EUR -7.1M
Free cash flow minus SBC	EUR -7.5M
Investing cash flow	EUR 2,000
Net borrowing	EUR -63,000
Net cash flow	EUR -2.4M
Net income	EUR -6.8M
Operating cash flow minus SBC	EUR -7.5M
Operating income	EUR -6.8M
Stock-based compensation	EUR 377,000

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	EUR 0.05
Debt / equity	0.05
Interest coverage	-154.09
Long-term assets	EUR 1M
Long-term liabilities	EUR 1.9M
Net cash (debt)	EUR 2.4M
Net cash / market cap	9.71%
Net cash growth	-50.26%
Net debt / equity	-1.51
Piotroski F-Score	1
Property, plant and equipment	EUR 82,000
Shareholders' equity	EUR 1.6M
Tangible book value	EUR 800,000
Tangible book value per share	EUR 0.03
Total assets	EUR 4.2M
Total cash	EUR 2.4M
Total debt	EUR 76,000
Total liabilities	EUR 2.6M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	EUR 3.1M
Current liabilities	EUR 688,000
Current ratio	4.56
Net working capital	EUR 69,000
Quick ratio	4.02
Working capital	EUR 2.5M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-10.09%
Shareholder yield	-10.09%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 1.16
1D price change	0.98%
1M price change	-24.57%
1M total return	-24.57%
1W price change	-7.61%
1W total return	-7.61%
1Y price change	-48.76%
1Y return CAGR	-48.78%
1Y total return	-48.76%
20-day SMA	EUR 0.98
200-day SMA	EUR 1.23
3M price change	-28.79%
3M total return	-28.79%
50-day SMA	EUR 1.06
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 1.66
52-week high date	2025-11-10
52-week low	EUR 0.82
52-week low date	2026-10-29
6M price change	-36.22%
6M total return	-36.22%
All-time high	EUR 1.99
All-time high date	2025-03-24
All-time low	EUR 0.82
All-time low date	2026-10-28
Average true range (ATR)	EUR 0.02
Average volume	0
Change from 52-week high	-50.3%
Change from 52-week low	0.98%
Change from all-time high	-58.45%
Change from all-time low	0.98%
Change from open	-0.24%
Day's gap	1.22%
High price	EUR 0.83
Low price	EUR 0.82
Monthly RSI	21.14
Open price	EUR 0.83
Position in 52-week range	80%
Previous close	EUR 0.82
Price vs 150-day SMA	-29.04%
Price vs 20-day SMA	-15.6%
Price vs 200-day SMA	-32.68%
Price vs 50-day SMA	-22%
Relative volume	20
RSI	19.46
Sharpe ratio	-1.96
Sortino ratio	-2.58
Weekly RSI	24.41
YTD price change	-42.88%
YTD total return	-42.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	26.3M
Shares change (QoQ)	6.35%
Shares change (YoY)	10.09%
Shares held by insiders	4.64%
Shares held by institutions	14.88%

Deeper analysis on VIE/VVYN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/VVYN report

Is a complete VIE/VVYN research report available?

No complete published report is available for vie/VVYN (VIE/VVYN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/VVYN (VIE/VVYN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/VVYN

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/VVYN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/VVYN

Frequently asked questions